Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Characterization of solid dispersions of lovastatin with pluronic f-127

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: PLUTA, Janusz (Wroclaw Medical Univeristy, Drug Form Technology, Wroclaw, Poland)
  • Co-author(s): Gajda, Maciej (Wroclaw Medical Univeristy, Wroclaw, Poland)
    Baranowski, Przemyslaw (Wroclaw Medical Univeristy, Wroclaw, Poland)
    Karolewicz, Bozena (Wroclaw Medical Univeristy, Wroclaw, Poland)
    Gorniak, Agata (Wroclaw Medical Univeristy, Wroclaw, Poland)
    Owczarek, Artur (Wroclaw Medical Univeristy, Wroclaw, Poland)
    Szymczak, Urszula (Wroclaw Medical Univeristy, Wroclaw, Poland)
  • Abstract:

    Lovastatin is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, which is commonly used as lipid regulating drug with actions on plasma lipids similar to those of simvastatin. Lovastatin is an example of a substance belonging to the second class of the Biopharmaceutical Classification System. According to the above mentioned..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses